Product Information
PRADAXA 150 MG CAPSULE is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $3.1629 per EA under NDC 00597036082. Its NADAC has been published 433 times since Mar 14, 2018.
Strength
150 mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597036082
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA022512On Market Since
7/28/2017
Pharmacological Classes
Price Statistics
The NADAC for PRADAXA 150 MG CAPSULE has been published 433 times since Mar 14, 2018, and over the history we have for it it has declined 50.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1629 per EA |
|---|---|
| All-time high | $7.9238 (Mar 15, 2023) |
| All-time low | $3.1501 (Jul 5, 2023) |
| 52-week high | $3.1692 |
| 52-week low | $3.1628 |
| Median price | $6.9249 |
| Average price | $5.8290 |
| Largest weekly change | -60.0% (Jul 5, 2023) |
| Weeks tracked | 433 |
| Tracking since | Mar 14, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PRADAXA 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PRADAXA 150 MG CAPSULE, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $3.1629 per EA (NDC 00597036082), effective Jun 24, 2026.
How has the price of PRADAXA 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PRADAXA 150 MG CAPSULE has declined 50.6%. It has been tracked across 433 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for PRADAXA 150 MG CAPSULE?
Since Mar 14, 2018, the NADAC for PRADAXA 150 MG CAPSULE has ranged from a low of $3.1501 (Jul 5, 2023) to a high of $7.9238 (Mar 15, 2023), with a median of $6.9249 per EA.
Are there cheaper alternatives to PRADAXA 150 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PRADAXA 150 MG CAPSULE, but none are currently priced below it.
Who manufactures PRADAXA 150 MG CAPSULE?
PRADAXA 150 MG CAPSULE (NDC 00597036082) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification